Skip to main content

Want a detailed portfolio tracker?

Design Therapeutics (DSGN) P/E (2021 - 2026)

Design Therapeutics (DSGN) P/E from Mar 26, 2021 to Jul 20, 2026. The TTM Design Therapeutics (DSGN) P/E is -10.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Design Therapeutics (DSGN)

YearP/EChange
2026-10.05+29.70%
2025-7.75+9.97%
2024-7.05+243.95%
2023-2.05-79.55%
2022-10.02-69.90%
2021-33.29N/A

Comparison Design Therapeutics (DSGN) P/E with competitors

Design Therapeutics (DSGN) P/E is -10.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.74%
FGENFibroGen Inc0.24-102.39%
CHRSCoherus Biosciences Inc0.85-108.44%
FBIOFortress Biotech Inc0.95-109.44%
ORMPOramed Pharmaceuticals Inc1.50-114.95%
AGENAgenus Inc3.01-129.94%
INVAInnoviva Inc3.15-131.38%
VXRTVaxart Inc3.55-135.31%
CRMDCorMedix Inc3.63-136.10%
CVACCureVac N.V.4.45-144.23%
GLPGGalapagos NV4.86-148.34%
SRPTSarepta Therapeutics Inc4.88-148.57%
ABEOAbeona Therapeutics Inc5.39-153.60%
ABUSArbutus Biopharma Corp5.60-155.67%
ZVRAZevra Therapeutics Inc5.89-158.57%
SPROSpero Therapeutics Inc6.23-161.96%
CGENCompugen Ltd6.31-162.81%
RIGLRigel Pharmaceuticals6.87-168.36%
SLXNSilexion Therapeutics Corp7.30-172.58%
OMEROmeros Corporation9.26-192.11%
AUPHAurinia Pharmaceuticals Inc9.58-195.35%
PLXProtalix BioTherapeutics Inc10.89-208.35%
ACADAcadia Pharmaceuticals Inc11.73-216.68%
TBPHTheravance Biopharma Inc12.26-221.99%
ADMAAdma Biologics Inc12.42-223.54%
HRMYHarmony Biosciences Holdings Inc13.82-237.49%
SABSSAB Biotherapeutics Inc14.14-240.63%
NAGENiagen Bioscience Inc14.82-247.41%
INCYIncyte Corp15.82-257.41%
REGNRegeneron Pharmaceuticals Inc15.86-257.74%
PBYIPuma Biotechnology Inc17.32-272.26%
CPRXCatalyst Pharmaceuticals Inc17.44-273.49%
EXELExelixis Inc17.54-274.47%
TGTXTG Therapeutics Inc18.97-288.68%
MDXGMimedx Group Inc20.55-304.46%
XOMAXOMA Royalty Corp22.87-327.57%
ARGXArgen X SE24.30-341.73%
CTMXCytomX Therapeutics Inc24.82-346.93%
XOMAOXOMA Royalty Corp25.34-352.14%
HALOHalozyme Therapeutics Inc25.62-354.92%
XOMAPXOMA Royalty Corp25.67-355.38%
VRTXVertex Pharmaceuticals Inc27.99-378.50%
RPRXRoyalty Pharma plc - Class A28.69-385.40%
SLNOSoleno Therapeutics Inc29.02-388.66%
ASNDAscendis Pharma A/S30.09-399.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-477.17%
APLSApellis Pharmaceuticals Inc39.02-488.20%
BMRNBiomarin Pharmaceutical Inc42.21-519.94%
KRYSKrystal Biotech Inc45.34-551.10%
ONCBeiGene Ltd69.54-791.82%
PHARPharming Group N.V.75.03-846.39%
TECHBio-Techne Corp101.96-1114.33%
VCELVericel Corp109.92-1193.55%
ALNYAlnylam Pharmaceuticals Inc117.96-1273.57%
GMABGenmab140.29-1495.68%
TLXTelix Pharmaceuticals Ltd162.15-1713.17%
CORTCorcept Therapeutics Inc212.86-2217.60%